Mackie Research Starts IntelliPharmaCeutics International (IPCI) at Spec. Buy
Tweet
Share
E-mailGet Alerts IPCI Hot Sheet
Price: $0.21 --0%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 1
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 1
Join SI Premium – FREE
Mackie Research initiated coverage on IntelliPharmaCeutics International (NASDAQ: IPCI) with a Spec. Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on IntelliPharmaCeutics International click here. For more ratings news on IntelliPharmaCeutics International click here.
Shares of IntelliPharmaCeutics International closed at $4.58 yesterday.
For an analyst ratings summary and ratings history on IntelliPharmaCeutics International click here. For more ratings news on IntelliPharmaCeutics International click here.
Shares of IntelliPharmaCeutics International closed at $4.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy
- Oil prices dip as Iran-Israel fears cool, economic jitters persist
- Oil prices recover on tight supply bets even as M.East fears clear
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
